Bone Health Technologies

There is an Escalating Rate of Osteoporosis Despite 25 Years of Drug Treatment Options

1 in 2 women and 1 in 4 men over 50 will suffer a bone density related fracture

“Fearing Drugs’ Rare Side Effects, Millions Take their Chances With Osteoporosis”
— New York Times

Introducing OsteoBoost

OsteoBoost is the first vibration belt specifically designed to improve bone strength and bone density.

SIMPLE YET EFFECTIVE

The OsteoBoost Vibration Belt applies gentle mechanical stimulation to the hips and spine to improve bone strength.

BASED ON NASA RESEARCH

Leveraging 15 years of published research (starting with NASA) proving that vibration at a precise amplitude and frequency stimulates bones, OsteoBoost delivers the optimal therapeutic dose directly to the most vulnerable anatomy, the hips and lumbar spine.

CLINICAL RESEARCH

OsteoBoost has been studied in multiple National Institutes of Health (NIH) funded clinical trials, based on a successful pilot study that showed a significant reduction in bone turnover markers after just one treatment.

EASY AND CONVENIENT

Comfortable and as easy as putting on a belt, one 30-minute treatment per day while doing chores or walking the dog makes OsteoBoost easy to fit into any lifestyle.

ADD ME TO NOTIFICATION LIST

Bone Mineral Density in Women Over Time

There are over 1 million hip and spine fractures each year due to osteopenia and osteoporosis

The OsteoBoost Difference

REDUCTION IN BONE LOSS ACTIVITY

In a recently published study, OsteoBoost induced an acute reduction in bone loss activity as measured by the biomarker NTx (mean: 14%, p<0.001).

COMPARABLE TO MEDICATION AND EXERCISE

Study results are consistent with the effects of high-impact exercise and the same order of magnitude as first-line osteoporosis medication.

GREAT EARLY INTERVENTION

OsteoBoost can be used safely during osteopenia whereas medications are used typically for osteoporosis.

HIGH COMPLIANCE

Compliance is high at over 80%.

Treatment Compliance Rate

Current medication treatments are used by less than 10% of patients for whom they are indicated and have a high rate of treatment discontinuation.

OsteoBoost is easy and convenient to use, with high compliance and satisfaction ratings.

Compliance

How It Works

The OsteoBoost Vibration Belt is as simple as 1-2-3, and includes an auto-shutoff feature that ends treatment after 30 minutes. Use daily or at least 4 days a week for full treatment effect.

Easy to attach velcro secures it around the waist.

STEP 1

Simply press power and it begins the gentle vibration treatment.

STEP 2

Once treatment beings, you can go about your business.

STEP 3

Chan et al., 2013. The potential benefits and inherent risks of vibration as a non-drug therapy for the prevention and treatment of osteoporosis. Curr Osteoporos Rep 11: p. 36-44.

NASA Research Leads to Vibration Belt Technology

Developed from NASA proven technology, OsteoBoost takes vibration therapy to another level by delivering precise mechanical stimulation targeted to the areas of the body that need it most, the hips and spine.

Our Team

Laura Yecies

CEO

Serial entrepreneur, formerly CEO at SyncThink, Catch (acq. Apple), and SugarSync (acq. J2). led multiple successful brands at Check Point, Netscape, Yahoo.

Derek Hillstrom

VP Engineering

20 years of medical device development and manufacturing at St Jude Medical, Autonomic Technologies and Niveus Medical

Meghan Griffin

Clinical Operations

Experienced running clinical trials for several novel medical devices.

Nina Peled

Regulatory

Regulatory expert experienced in obtaining FDA clearances/approvals of all types, including 510k, PMA, de novo, and ‎EUA

Gabriel Griego

Marketing

Seasoned sales & marketing leader. Track-record of successfully designing and executing go-to-market for consumer/medical products. Led marketing for PowerBar, Game Ready, and AlterG.

Board Members

Laura Yecies

CEO, MBA, MSFS

Serial entrepreneur, formerly CEO at SyncThink, Catch (acq. Apple), and SugarSync (acq. J2). led multiple successful brands at Check Point, Netscape, Yahoo.

Dan Burnett

Founder, MD, MBA

Experienced entrepreneur; Founder of 10 startups with >$225M in investments for these companies. Track-record of bringing companies from concept to successful commercial launch.

Shane Mangrum

Founder, MD

Physical Medicine and Rehabilitation (PM&R) physician at Polaris Spine in Atlanta, GA; Specialist in non-operative spine and musculoskeletal care. Dr. Mangrum is also a co-inventor of the OsteoBoost technology

Karen Drexler

MBA

Founded and ran Amira Medical through the sale to Roche, Manager at LifeScan and executed the sale to J&J, CEO of Sandstone Diagnostics, guest lecturer at Stanford, active board member at a variety of major medical device/diagnostic companies. Engineering background with deep business and entrepreneurial experience.

Dr. Nancy Lynch

MD, MBA

President of Advisorthopædics, Board-certified orthopedic surgeon and fellow of the American Academy of Orthopædic Surgeons. B.A. from the University of Notre Dame, M.D. from the Washington University School of Medicine, completed residency at the Mayo Clinic and an MBA from Duke. Experience as a venture capitalist, and as an executive within startup companies.

Dr. Sam Goldberger

MD, MBA

Co-Founder and Managing Partner of Ambit Health Ventures. Ophthalmologist and ophthalmic surgeon. Board certified by the American Academy of Ophthalmology and member of the American Society of Ophthalmic Plastic & Reconstructive Surgery. MD from Albert Einstein College of Medicine, and MBA from MIT Sloan. Led a successful ophthalmology practice roll up and founded a healthcare and life-science investing firm.

John Osborne

Over a decade working various roles in the finance industry including in commercial banking, private banking and angel investing. Co-founded and Director of The Harbor Entrepreneur Center, Charleston. Executive Administrator of Charleston Angel Partners. B.S. in Finance from Charleston Southern University

Advisors & Investigators

Harold Rosen

Professor of Endocrinology at Harvard Medical School, Director Osteoporosis Prevention and Treatment Center at Beth Israel Deaconess Medical Center, leading expert in bone densitometry, biochemical markers of bone turnover and metabolic bone disease.

David B. Karpf

Professor of Endocrinology at Stanford University School of Medicine, Director Stanford Osteoporosis and Metabolic Bone Disease Clinic, leading researcher on Osteoporosis medications (Fosomax trial) and board member of American Bone Health

Dolores Shoback

Professor of Medicine, UCSF, Staff Physician San Francisco, VA, and board member of American Bone Health. Dr. Shoback is a recognized authority in metabolic bone disease, parathyroid disorders and osteoporosis. She also co-directs UCSF’s physician training program in diabetes, endocrinology and metabolism.

Anne Schafer

Chief of Endocrinology and Metabolism San Francisco, VA, Associate Professor of Medicine and Epidemiology & Biostatistics at UCSF. Dr. Schafer is an expert on optimizing osteoporosis treatment and the relationships between bone, fat, and glucose metabolism.

Laura Bilek

PhD, PT

Associate Dean for Research in the College of Allied Health Professions at the University of Nebraska Medical Center (UNMC). Expert in clinical research for the treatment of low bone mass.

Tony Keaveny

PhD

Professor of Mechanical Engineering and Bioengineering, UC Berkeley, director of the Berkeley Orthopaedic Biomechanics Lab; Expert in bone mechanics and inventor of VirtuOst.